| 000 | 01310 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250514214550.0 | ||
| 264 | 0 | _c20050915 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a1538-4047 | ||
| 024 | 7 |
_a10.4161/cbt.4.1.1379 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMatta, Hittu | |
| 245 | 0 | 0 |
_aThe proteasome inhibitor bortezomib (PS-341) inhibits growth and induces apoptosis in primary effusion lymphoma cells. _h[electronic resource] |
| 260 |
_bCancer biology & therapy _cJan 2005 |
||
| 300 |
_a77-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aBoronic Acids _xpharmacology |
| 650 | 0 | 4 | _aBortezomib |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aHerpesviridae Infections _xcomplications |
| 650 | 0 | 4 |
_aHerpesvirus 8, Human _xpathogenicity |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xpathology |
| 650 | 0 | 4 |
_aPyrazines _xpharmacology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aChaudhary, Preet M | |
| 773 | 0 |
_tCancer biology & therapy _gvol. 4 _gno. 1 _gp. 77-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4161/cbt.4.1.1379 _zAvailable from publisher's website |
| 999 |
_c15341013 _d15341013 |
||